Foundation Consumer Healthcare (FCH), a maker of popular over-the-counter drugs including Plan B One-Step emergency contraceptive, is leaving the 340B program at the end of this year.
In a Nov. 3 letter to customers, FCH did not say why it is voluntarily exiting the drug pricing program. A company senior executive who signed the letter did not immediately respond to a request for comment.
Foundation Consumer Healthcare (FCH), a maker of popular over-the-counter drugs including Plan B One-Step emergency contraceptive, is leaving the 340B program at the end of this year.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
